The antiretrovirus drug 3'-azido-3'-deoxythymidine increases the retrovirus mutation rate

Journal of Virology

Volumn 71, Issue 6, 1997, Pages 4254-4263

  Julias, John G ^a   Kim, Theodore ^a   Arnold, Gregory ^a   Pathak, Vinay K ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BETA GALACTOSIDASE; HYDROXYUREA; LAMIVUDINE; RNA DIRECTED DNA POLYMERASE; VIRUS VECTOR; ZIDOVUDINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DOG; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MURINE LEUKEMIA VIRUS; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; PROVIRUS; RETROVIRUS; SHUTTLE VECTOR; VIRUS GENE; VIRUS MUTANT; VIRUS MUTATION; VIRUS REPLICATION;

EID: 0031000316     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.6.4254-4263.1997     Document Type: Article

References (54)

1. Bebenek, K., J. Abbots, J. D. Roberts, S. H. Wilson, and T. A. Kunkel. 1989. Specificity and mechanism of error-prone replication by human immunodeficiency virus-1 reverse transcriptase. J. Biol. Chem. 264:16948-16956.
2. Cepko, C. 1992. XGAL staining of cultured cells, p. 9.11.9-9.11.12. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology. Greene Publishing Associates and Wiley Interscience, New York, N.Y.
3. Coffin, J. M. 1990. Genetic variation in retroviruses, p. 11-33. In E. Kurstak, R. G. Marusyk, F. A. Murphy, and M. H. V. Van Regenmortel (ed.), Applied virology research, virus variability, epidemiology and control. Plenum Press, New York, N.Y.
4. Coffin, J. M. 1990. Retroviridae and their replication, p. 1437-1500. In B. Fields (ed.), Virology, 2nd ed. Raven Press, New York, N.Y.
5. Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267:483-489.
6. Dougherty, J. P., and H. M. Temin. 1988. Determination of the rate of hase-pair substitution and insertion mutations in retrovirus replication. J. Virol. 62:2817-2822.
7. El-Farrash, M. A., M. J. Kuroda, T. Kitazaki, T. Masuda, K. Kato, M. Hatanaka, and S. Harada. 1994. Generation and characterization of a human immunodeficiency virus type 1 (HIV-1) mutant resistant to an HIV-1 protease inhibitor. J. Virol. 68:233-239.
8. Essex, M. 1995. Strategies of research for a vaccine against AIDS. Pubbl. Stn. Zool. Napoli II 17:141-149.
9. Fitzgibbon, J. E., R. M. Howell, C. A. Haberzettl, S. J. Sperber, D. J. Gocke, and D. T. Dubin. 1992. Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2′-3′-dideoxycytidine. Antimicrob. Agents Chemother. 36:153-157.
10. Frick, L. W., D. J. Nelson, M. H. St. Clair, P. A. Furman, and T. A. Krenitsky. 1988. Effects of 3′-azido-3′-deoxythymidine on the deoxynucleotide triphosphate pools of cultured human cells. Biochem. Biophys. Res. Commun. 154:124-129.
11. Furman, P. A., J. A. Fyfe, M. H. St. Clair, K. Weinhold, J. L. Rideout, G. A. Freemen, S. N. Lehrman, D. P. Bolognesi, S. Broder, H. Mitsuya, and D. W. Barry. 1986. Phosphorylation of 3′-azido-3′deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc. Natl. Acad. Sci. USA 83:8333-8337.
12. Gao, W.-Y., A. Cara, R. C. Gallo, and F. Lori. 1993. Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication. Proc. Natl. Acad. Sci. USA 90: 8925-8928.
13. Glickman, B. W., V. A. Saddi, and J. Curry. 1994. Spontaneous mutations in mammalian cells. Mutat. Res. 304:19-32.
14. Gritz, L., and J. Davies. 1979. Plasmid encoded hygromycin-b resistance: the sequence of hygromycin b phosphotransferase and its expression. Gene 25:179-188.
15. Gu, Z., Q. Gao, X. Li, M. Parniak, and M. A. Wainberg. 1992. Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2′,3′-dideoxyinosine and 2′,3′-dideoxycytidine. J. Virol. 66:7128-7135.
16. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126.
17. Hu, W.-S., and H. M. Temin. 1990. Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and a high rate of genetic recombination. Proc. Natl. Acad. Sci. USA 87:1556-1560.
18. Japour, A. J., S. Welles, R. T. D'Aquilla, V. A. Johnson, D. D. Richman, R. W. Coombs, P. S. Reichelderfer, J. O. Kahn, C. S. Crumpacker, and D. R. Kuritzkes. 1995. Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. J. Infect. Dis. 171:1172-1179.
19. Ji, J., and L. A. Loeb. 1992. Fidelity of HIV-1 reverse transcriptase copying RNA in vitro. Biochemistry 31:954-958.
20. Jorgensen, R. A., S. J. Rothstein, and W. J. Reznikoff. 1979. A restriction enzyme cleavage map of Tn5 and location of a region encoding neomycin resistance. Mol. Gen. Genet. 177:65-72.
21. Kawai, S., and M. Nishizawa. 1984. New procedures for DNA transfection with polycation and dimethyl sulfoxide. Mol. Cell. Biol. 4:1172-1174.
22. Kim, T., R. A. Mudry, Jr., C. A. Rexrode II, and V. K. Pathak. 1996. Retroviral mutation rates and A-to-G hypermutations during different stages of retroviral replication. J. Virol. 70:7594-7602.
23. Kunkel, T. A., and P. S. Alexander. 1986. The base substitution fidelity of eucaryotic DNA polymerases - mispairing frequencies, site preferences, insertion preferences, and base substitution by dislocation. J. Biol. Chem. 261:160-166.
24. Kunz, B. A., and S. E. Kohalmi. 1991. Modulation of mutagenesis by deoxyribonucleotide levels. Annu. Rev. Genet. 25:339-359.
25. Kunz, B. A., and S. E. Kohalmi. 1993. Mutational specificity of thymidine depletion in yeast. Mut. Res. 289:73-81.
26. LaCasse, R. A., K. M. Remington, and T. W. North. 1996. The mutation frequency of feline immunodeficiency virus enhanced by 3′-azido-3′-deoxythymidine. J. Acquired Immune Defic. Syndr. Hum. Retroviruses 12:26-32.
27. Larder, B. A., G. Darby, and D. D. Richman. 1989. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 243:1731-1734.
28. Larder, B. A., and S. D. Kemp. 1989. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science 246: 1155-1158.
29. Libby, R. T., and J. A. Gallant. 1994. Phosphorlytic error correction during transcription. Mol. Microbiol. 12:121-129.
30. Loeb, L. A., and T. A. Kunkel. 1982. Fidelity of DNA synthesis. Annu. Rev. Biochem. 51:429-157.
31. Lori, F., A. Malykh, A. Cara, D. Sun, J. N. Weinstein, J. Lisziewicz, and R. C. Gallo. 1994. Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication. Science 266:801-805.
32. Mansky, L. M., and H. M. Temin. 1994. Lower mutation rate of bovine leukemia virus relative to that of spleen necrosis virus. J. Virol. 68:494-499.
33. Mansky, L. M., and H. M. Temin. 1995. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69:5087-5094.
34. Martinez, M. A., J.-P. Vartanian, and S. Wain-Hobson. 1994. Hypermutagenesis of RNA using human immunodeficiency virus type 1 reverse transcriptase and biased dNTP concentrations. Proc. Natl. Acad. Sci. USA 91:11787-11791.
35. Meuth, M. 1989. The molecular basis of mutations induced by deoxyribonucleoside triphosphate pool imbalances in mammalian cells. Exp. Cell Res. 181:305-316.
36. Milich, L., B. Margolin, and R. Swanstrom. 1993. V3 Loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability. J. Virol. 67:5623-5634.
37. Miller, A. D., J. V. Garcia, N. von Suhr, C. M. Lynch, C. Wilson, and M. V. Eiden. 1991. Construction and properties of retrovirus packaging cell lines based on gibbon ape leukemia virus. J. Virol. 65:2220-2224.
38. Moore, H. H. P., R. H. Raasch, K. L. R. Brouwer, K. Opheim, S. H. Cheeseman, E. Eyster, S. M. Lemon, and C. M. van der Horst. 1995. Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease (AIDS clinical trials group protocol 062). Antimicrob. Agents Chemother. 39:2732-2737.
39. Parthasarathi, S., A. Varela-Echavarria, Y. Ron, B. D. Preston, and J. P. Dougherty. 1995. Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: characterization and implications. J. Virol. 69:7991-8000.
40. Pathak, V. K., and H. M. Temin. 1990. Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations. Proc. Natl. Acad. Sci. USA 87:6019-6023.
41. Pathak, V. K., and H. M. Temin. 1990. Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. Proc. Natl. Acad. Sci. USA 87:6024-6028.
42. Pathak, V. K., and H. M. Temin. 1992. 5-Azacytidine and RNA secondary structure increase the retrovirus mutation rate. J. Virol. 66:3093-3100.
43. Patick, A., R. Rose, J. Greytok, C. M. Bechtold, M. A. Hermsmeier, P. T. Chen, J. C. Barrish, R. Zahler, R. J. Colonno, and P.-F. Lin. 1995. Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitor. J. Virol. 69:2148-2152.
44. Preston, B. D., B. J. Poiesz, and L. A. Loeb. 1988. Fidelity of HIV-1 reverse transcriptase. Science 242:1168-1171.
45. Roberts, J. D., K. Bebenek, and T. A. Kunkel. 1988 The accuracy of reverse transcriptase from HIV-1. Science 242:1171-1173.
46. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
47. Shirasaka, T., M. F. Kavlick, T. Ueno, W.-Y. Gao, E. Kojima, M. L. Alcaide, S. Chokekijchai, B. M. Roy, E. Arnold, R. Yarchoan, and H. Mitsuya. 1995. Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides. Proc. Natl. Acad. Sci. USA 92:2398-2402.
48. St. Clair, M. H., J. L. Martin, G. Tudor-Williams, M. C. Bach, C. L. Vavro, D. M. King, P. Kellam, S. D. Kemp, and B. A. Larder. 1991. Resistance to ddl and sensitivity to AZT induced by a mutation in the HIV-1 reverse transcriptase. Science 253:1557-1559.
49. Temin, H. M. 1993. Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation. Proc. Natl. Acad. Sci. USA 90:6900-6903.
50. Tisdale, M., S. D. Kemp, N. R. Parry, and B. A. Larder. 1993. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3′-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase. Proc. Natl. Acad. Sci. USA 90:5653-5656.
51. Varela-Echavarria, A., N. Garvey, B. D. Preston, and J. P. Dougherty. 1992. Comparison of Moloney murine leukemia virus mutation rate with the fidelity of its reverse transcriptase in vitro. J. Biol. Chem. 267:24681-24688.
52. Wainberg, M. A., W. C. Drosopoulos, H. Salomon, M. Hsu, G. Borkow, M. A. Parniak, Z. Gu, Q. Song, J. Manne, S. Islam, G. Castriota, and V. R. Prasad. 1996. Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase. Science 271:1282-1285.
53. Watanabe, S., and H. M. Temin. 1983. Construction of a helper cell line for reticuloendotheliosis virus cloning vectors. Mol. Cell. Biol. 3:2241-2249.
54. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Sag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122.